Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks
Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery
1 other identifier
interventional
98
1 country
1
Brief Summary
Mohs Micrographic Surgery is a well established method for treatment of cutaneous malignancies. Part of this technique requires marking skin surrounding the tumor. There are two ways of marking the tissue, lightly scoring it with a scalpel or marking it with a surgical marker. This study is to determine if there is a noticeable difference in outcome between patients who have their tissue lightly scored with a scalpel or marked with a surgical marking pen.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jul 2005
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 19, 2006
CompletedFirst Posted
Study publicly available on registry
August 22, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedApril 16, 2015
April 1, 2015
1 year
August 19, 2006
April 15, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The goal of the study is to determine if there are any noticeable differences in outcomes between patients who have their skin scored and those who have their skin marked with a surgical marking pen
2 Years
Study Arms (1)
1
NO INTERVENTIONInterventions
During Mohs surgery we will compare the outcomes of scarring, to determine whether a mark (with a pen) or a score with a scalpel will receive the best scar.
You will be asked to participate, examined, discuss participation have procedure and come in for follow up for photos and check up.
Eligibility Criteria
You may qualify if:
- Patients who are able to legally consent to study and are scheduled for Mohs Micrographic Surgery to remove their malignancies
You may not qualify if:
- Patients who are unable to legally consent themselves, do not wish to participate or who are not scheduled to undergo Mohs Micrographic Surgery.
- Children, those with mental handicaps, pregnant women, prisoners, those with cognitive impairments, and life-threatening diseases will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Davis Medical Center Department of Dermatology
Sacramento, California, 95816, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Eisen, MD
University of California, Davis
- PRINCIPAL INVESTIGATOR
Thomas King, MD
University of California, Davis
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2006
First Posted
August 22, 2006
Study Start
July 1, 2005
Primary Completion
July 1, 2006
Study Completion
July 1, 2008
Last Updated
April 16, 2015
Record last verified: 2015-04